Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrest Nicholson Regulatory News (CRST)

Share Price Information for Crest Nicholson (CRST)

Share Price is delayed by 15 minutes
Get Live Data
67.70    -1.50 (-2.17%)
Bid:
67.30
Ask:
67.80
Spread: 0.50 (0.743%)
Market Cap: £173.81m
CRST Live PriceLast checked at - London Stock Exchange

Intraday Crest Nicholson Share Chart

Form 8.5 (EPT/RI)

28 Jun 2024 09:10

RNS Number : 3410U
Citigroup Global Markets Limited
28 June 2024
 

 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH

RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

(a) Name of exempt principal trader:

Citigroup Global Markets Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

 Use a separate form for each offeror/offeree

Crest Nicholson Holdings plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Bellway plc

(d) Date dealing undertaken:

27 June 2024

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

 If it is a cash offer or possible cash offer, state "N/A"

Bellway plc

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

5p ordinary

Purchase

42,818

GBP 2.3920

GBP 2.3800

5p ordinary

Sale

58,143

GBP 2.3920

GBP 2.3800

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

 e.g. CFD

Nature of dealing

 e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

5p ordinary

TRS

Opening Long Position

15,325

GBP 2.3800

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description

 e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

 e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

 e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

 e.g. subscription, conversion

Details

Price per unit (if applicable)

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

 Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

 If there are no such agreements, arrangements or understandings, state "none"

None

 

Date of disclosure:

28 June 2024

Contact name:

Cathal McKenna

Telephone number:

02890 409 544

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panels Market Surveillance Unit is available for consultation in relation to the Codes dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panels website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERGZGZVRRLGDZG
Date   Source Headline
10th May 20211:00 pmRNSHolding(s) in Company
4th May 20211:03 pmRNSDirectorate Change
19th Apr 20212:31 pmRNSBlock listing Interim Review
23rd Mar 20214:26 pmRNSResult of AGM
23rd Mar 20217:00 amRNSAGM Statement
15th Mar 20219:27 amRNSHolding(s) in Company
5th Mar 20211:56 pmRNSHolding(s) in Company
4th Mar 20214:17 pmRNSHolding(s) in Company
25th Feb 20215:14 pmRNSHolding(s) in Company
16th Feb 20217:00 amRNSAnnual Integrated Report and Notice of AGM
10th Feb 20211:52 pmRNSDirector/PDMR Shareholding
26th Jan 20217:00 amRNSFinal Results
21st Jan 20215:14 pmRNSHolding(s) in Company
24th Nov 20203:18 pmRNSHolding(s) in Company
3rd Nov 20207:00 amRNSTrading Statement
19th Oct 20209:00 amRNSBlock listing Interim Review
23rd Sep 20204:49 pmRNSDirector/PDMR Shareholding
23rd Sep 202012:32 pmRNSDirector/PDMR Shareholding
22nd Sep 20209:16 amRNSDirector/PDMR Shareholding
22nd Sep 20209:14 amRNSDirector/PDMR Shareholding
21st Sep 202012:48 pmRNSHolding(s) in Company
11th Aug 20207:00 amRNSDirector/PDMR Shareholding
7th Aug 20201:51 pmRNSHolding(s) in Company
5th Aug 202012:43 pmRNSHolding(s) in Company
5th Aug 202011:19 amRNSDirector/PDMR Shareholding
24th Jul 20208:00 amRNSDirector/PDMR Shareholding
6th Jul 20202:54 pmRNSDirector/PDMR Shareholding
3rd Jul 20201:03 pmRNSDirector/PDMR Shareholding
3rd Jul 202010:36 amRNSDirector/PDMR Shareholding
29th Jun 202010:31 amRNSDirector Declaration
26th Jun 202011:48 amRNSDirector/PDMR Shareholding
26th Jun 202011:34 amRNSDirector/PDMR Shareholding
26th Jun 202011:34 amRNSDirector/PDMR Shareholding
26th Jun 202010:18 amRNSDirector/PDMR Shareholding
26th Jun 202010:15 amRNSDirector/PDMR Shareholding
24th Jun 20207:00 amRNSHalf-year Report
19th Jun 202011:49 amRNSHolding(s) in Company
18th Jun 20201:29 pmRNSCovid Corporate Finance Facility
5th Jun 20204:33 pmRNSHolding(s) in Company
3rd Jun 20203:29 pmRNSHolding(s) in Company
1st Jun 20203:12 pmRNSHolding(s) in Company
20th May 20207:00 amRNSHolding(s) in Company
13th May 20207:00 amRNSCOVID-19 Update
1st May 20201:38 pmRNSDirector Declaration
27th Apr 202010:52 amRNSDisclosure of Rights Attached to Equity Shares
17th Apr 202010:00 amRNSBlock listing Interim Review
9th Apr 20204:02 pmRNSCOVID-19 Update
2nd Apr 20205:10 pmRNSHolding(s) in Company
2nd Apr 20209:35 amRNSHolding(s) in Company
2nd Apr 20209:30 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.